Medicare Enrolled
Dr. Waseemullah Khan, MD
Medical Oncology · Lake City, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Waseemullah Khan is a medical oncology in Lake City, FL, with 19 years in practice. Based on federal Medicare data, Dr. Khan performed 242,504 Medicare services across 8,285 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $21,848 from 108 pharmaceutical and/or device companies across 1017 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 9% volume in FL$ $21,848 industry payments
Medicare Practice Summary
Medicare Utilization ↗242,504
Medicare services
Top 9% in FL for medical oncology
8,285
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12,763 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 96,390 | $0 | $4 |
| Iron infusion (Injectafer) | 85,500 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 19,320 | $18 | $73 |
| Anti-nausea injection (fosaprepitant) | 10,350 | $0 | $9 |
| Complete blood count (CBC) with differential | 3,745 | $8 | $64 |
| Blood draw (venipuncture) | 3,072 | $8 | $18 |
| Epoetin alfa injection (Procrit) for anemia | 2,860 | $6 | $52 |
| Comprehensive metabolic blood panel | 1,885 | $10 | $87 |
| Office visit, established patient (20-29 min) | 1,847 | $67 | $293 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 1,840 | $0 | $1 |
| Dexamethasone injection (steroid) | 1,680 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,450 | $1 | $89 |
| Injection, magnesium sulfate, per 500 mg | 1,424 | $1 | $3 |
| Office visit, established patient (30-39 min) | 1,331 | $97 | $430 |
| Drug injection, under skin or into muscle | 706 | $11 | $130 |
| Ferritin level test (iron stores) | 689 | $13 | $112 |
| Iron level test | 674 | $6 | $53 |
| Iron binding capacity test | 644 | $9 | $72 |
| Hospital follow-up visit, moderate complexity | 615 | $64 | $410 |
| Vitamin B-12 level test | 565 | $15 | $94 |
| Folic acid level test | 560 | $14 | $94 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 442 | $48 | $379 |
| Administration of chemotherapy into vein, 1 hour or less | 433 | $100 | $718 |
| Injection of additional new drug or substance into vein | 402 | $12 | $113 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 355 | $135 | $1,298 |
| Anti-nausea injection (ondansetron/Zofran) | 341 | $0 | $2 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 243 | $25 | $164 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 243 | $1 | $9 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 223 | $15 | $109 |
| Initial hospital admission, high complexity | 208 | $137 | $1,162 |
| Administration of chemotherapy into vein, each additional hour | 203 | $22 | $154 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 188 | $22 | $160 |
| Testosterone (hormone) level, total | 184 | $25 | $121 |
| Hospital follow-up visit, high complexity | 181 | $96 | $592 |
| PSA test (prostate cancer screening) | 179 | $18 | $152 |
| Magnesium level test | 164 | $7 | $55 |
| Chronic care management, first 20 min/month | 128 | $50 | $319 |
| New patient office visit, complex (60-74 min) | 118 | $166 | $806 |
| Lactate dehydrogenase (enzyme) level | 111 | $6 | $32 |
| Administration of additional new drug or substance into vein, 1 hour or less | 91 | $50 | $357 |
| Infusion into a vein for hydration, each additional hour | 85 | $10 | $83 |
| Office visit, established patient, complex (40-54 min) | 82 | $135 | $576 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 71 | $49 | $306 |
| Carcinoembryonic antigen (cea) protein level | 69 | $19 | $156 |
| Injection, diphenhydramine hcl, up to 50 mg | 69 | $1 | $3 |
| Thyroid stimulating hormone (TSH) test | 68 | $16 | $135 |
| Phosphate level test | 58 | $5 | $39 |
| Injection, zoledronic acid, 1 mg | 55 | $7 | $495 |
| Chronic care management, additional 20 min/month | 54 | $37 | $234 |
| Irrigation of implanted venous access drug delivery device | 52 | $16 | $126 |
| Drawing of blood for a medical problem | 52 | $66 | $309 |
| Infusion into a vein for hydration, 31-60 minutes | 43 | $25 | $294 |
| Unclassified drugs | 40 | $1 | $71 |
| Red blood count, automated test | 39 | $4 | $20 |
| Automated urinalysis | 28 | $2 | $17 |
| Prothrombin time test (blood clotting) | 23 | $4 | $26 |
| Injection of drug or substance into vein | 17 | $29 | $289 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 15 | $138 | $1,038 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
75.4% high complexity
17.2% medium
7.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,848
Total received (2018-2024)
Avg $3,121/year across 7 years
Top 24% in FL for medical oncology
108
Companies
1,017
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,924 (91.2%)
Other
Charitable contributions, space rental, and other categories
$1,038 (4.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$886 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,153
2023$3,338
2022$4,558
2021$2,584
2020$1,896
2019$2,883
2018$2,436
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,970
US Oncology Corporate, Inc.
$1,855
PFIZER INC.
$1,228
AstraZeneca Pharmaceuticals LP
$1,141
E.R. Squibb & Sons, L.L.C.
$936
Incyte Corporation
$932
Amgen Inc.
$919
Merck Sharp & Dohme Corporation
$666
Janssen Biotech, Inc.
$598
Lilly USA, LLC
$530
Genentech USA, Inc.
$530
Celgene Corporation
$527
Merck Sharp & Dohme LLC
$508
Seagen Inc.
$434
Astellas Pharma US Inc
$401
Daiichi Sankyo Inc.
$391
Exelixis Inc.
$377
Takeda Pharmaceuticals U.S.A., Inc.
$363
Abbott Laboratories
$315
EMD Serono, Inc.
$299
Bayer HealthCare Pharmaceuticals Inc.
$298
Eisai Inc.
$290
GENZYME CORPORATION
$285
Gilead Sciences, Inc.
$268
McKesson Specialty Care Distribution, LLC
$266
Foundation Medicine, Inc.
$261
Regeneron Healthcare Solutions, Inc.
$243
Octapharma USA, Inc.
$215
Bayer Healthcare Pharmaceuticals Inc.
$194
Ipsen Biopharmaceuticals, Inc
$176
Seattle Genetics, Inc.
$165
SERVIER PHARMACEUTICALS LLC
$156
Rigel Pharmaceuticals, Inc.
$146
Taiho Oncology, Inc.
$143
Varian Medical Systems, Inc.
$138
Pharmacyclics LLC, An AbbVie Company
$132
Boehringer Ingelheim Pharmaceuticals, Inc.
$123
Alexion Pharmaceuticals, Inc.
$117
EISAI INC.
$116
ABBVIE INC.
$114
CTI BioPharma Corp.
$103
Siemens Medical Solutions USA, Inc.
$101
GlaxoSmithKline, LLC.
$100
Heron Therapeutics, Inc.
$99
Biogen, Inc.
$99
Global Blood Therapeutics, Inc.
$92
PharmaEssentia USA Corporation
$91
Stemline Therapeutics Inc.
$89
Agios Pharmaceuticals, Inc.
$88
TESARO, Inc.
$83
Medtronic USA, Inc.
$79
Blue Earth Diagnostics Limited
$79
Sun Pharmaceutical Industries Inc.
$73
ARRAY BIOPHARMA INC
$71
SOBI, INC
$71
AbbVie Inc.
$70
TAIHO ONCOLOGY, INC.
$70
Blueprint Medicines Corporation
$69
G1 Therapeutics, Inc.
$67
TerSera Therapeutics LLC
$64
Adaptive Biotechnologies Corporation
$62
MEDIVATION FIELD SOLUTIONS LLC
$60
Pharmacyclics LLC, an AbbVie Company
$60
BeiGene USA, Inc.
$60
Medtronic, Inc.
$59
Horizon Therapeutics plc
$58
Lexicon Pharmaceuticals, Inc.
$54
Dova Pharmaceuticals
$49
Dendreon Pharmaceuticals LLC
$47
Elekta, Inc.
$44
Clovis Oncology, Inc.
$43
Helsinn Therapeutics (U.S.), Inc.
$43
Teva Pharmaceuticals USA, Inc.
$41
Pharmacosmos Therapeutics Inc.
$38
Secura Bio, Inc.
$38
Mirati Therapeutics, Inc.
$38
Myriad Genetic Laboratories, Inc.
$35
Array BioPharma Inc.
$35
Sumitomo Pharma America, Inc.
$32
Puma Biotechnology, Inc.
$31
Servier Pharmaceuticals LLC
$30
RECORDATI_RARE_DISEASES_INC.
$29
PUMA BIOTECHNOLOGY, INC.
$29
Kite Pharma, Inc.
$28
Aurobindo Pharma USA, Inc.
$27
Geron Corporation
$24
SANOFI-AVENTIS U.S. LLC
$22
R-Pharm US LLC
$22
EUSA Pharma (US) LLC
$19
TOLMAR Pharmaceuticals, Inc.
$18
Sobi, Inc
$17
Verity Pharmaceuticals Inc.
$17
GE HealthCare
$16
Shire North American Group Inc
$16
TG Therapeutics, Inc.
$16
INSYS Therapeutics Inc
$15
Myovant Sciences Inc.
$15
Deciphera Pharmaceuticals Inc.
$15
Coherus Biosciences Inc.
$14
Jazz Pharmaceuticals Inc.
$14
Tolmar, Inc.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Spectrum Pharmaceuticals Inc.
$12
AMAG Pharmaceuticals, Inc.
$12
Kyowa Kirin, Inc.
$12
Janssen Pharmaceuticals, Inc
$11
SECURA BIO, INC.
$9
Top 3 companies account for 23.1% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADUHELM · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AMPLATZER AMULET · AVEIR · AYVAKIT · Alecensa · Aliqopa · Avastin · Axumin · BAVENCIO · BENDEKA · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Biograph mCT X-4R · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELEKTA MEDICAL LINEAR ACCELERATOR · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · EVENITY · EXKIVITY · Enhertu · Erleada · FARYDAK · FEMARA · FERAHEME · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GATTEX · GAVRETO · GAZYVA · GILOTRIF · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INTERSTIM · Imbruvica · Ixempra · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trelstar · Trodelvy · TrueBeam · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zevalin · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
3
Per 100K population
4.2
County median income
$55,070
Nearest hospital
VA NORTH FLORIDA/SOUTH GEORGIA HEALTHCARE SYSTEM - LAKE CITY
9.9 mi
9.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khan is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Khan performed 96,390 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $21,848 from 108 companies across 1,017 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other medical oncologys in Lake City?
Dr. Khan's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Lake City
Browse medical oncologys in Lake City ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
US Oncology Corporate, Inc. Payments to Doctors
See all physicians who received payments from US Oncology Corporate, Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology